Skip to main content
Equibles

Woodline Partners LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1784547 San Francisco, CA
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,736,568
+$2,137,254 QoQ
Shares Held
171,805
0.0% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#77
of 311 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. RARE ranks #126 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in RARE

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,736,568 171,805
2026-03-31 $3,599,314 171,805
2025-12-31 $3,951,515 171,805
2025-09-30 $8,219,390 273,251
2025-06-30 $9,935,406 273,251
2025-03-31 $9,721,009 268,462
2024-12-31 $11,340,220 269,556
2024-09-30 $14,862,680 267,555
2024-06-30 $10,965,069 266,790
2024-03-31 $18,681,789 400,124
2023-12-31 $19,133,929 400,124
2023-09-30 $7,325,468 205,483
2023-06-30 $10,912,697 236,564